touchPANEL DISCUSSION for touchNEUROLOGY
Listen to a panel of leading multiple sclerosis (MS) experts discuss their perspectives on the benefits of disease-modifying therapies (DMTs) in MS, and current approaches to treatment sequencing.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from the Healthcare Business of Merck KGaA, Darmstadt, Germany. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurology.com/cme/treatment-sequencing-in-ms-the-benefits-of-dmts/
Managing disease progression: Considerations for treatment selection and sequencing
Supporting treatment adherence: What strategies are needed for safety management?
Mapping an individualized treatment plan: What role does the MDT play?
Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Managing disease progression: Considerations for treatment selection and sequencing
Supporting treatment adherence: What strategies are needed for safety management?
Mapping an individualized treatment plan: What role does the MDT play?
Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Managing disease progression: Considerations for treatment selection and sequencing
Supporting treatment adherence: What strategies are needed for safety management?
Mapping an individualized treatment plan: What role does the MDT play?
Achieving a timely and accurate diagnosis: How can multidisciplinary input address current challenges?
Understanding alopecia areata: Current perspectives and emerging therapies for a complex disease
Advancing the management of MDS and AML: Novel immune-based approaches
Experts in cytomegalovirus in solid organ transplants discuss management strategies and emerging therapeutic options
Experts in cytomegalovirus in solid organ transplants discuss management strategies and emerging therapeutic options
What’s new for eosinophilic esophagitis? A case-based discussion of patient care
What’s new for eosinophilic esophagitis? A case-based discussion of patient care
Higher-risk MDS and newly diagnosed AML What are the latest developments from EHA 2022
Advances in the first-line treatment of ES-SCLC: From clinical data to daily practice
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
The Psychic Elephant Radio Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain